Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs

NCT01365429 is registered in ClinicalTrials.gov with XVIVO Perfusion as lead sponsor.

NCT NCT01365429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01365429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
Lead sponsor
XVIVO Perfusion
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2011
Completion date
December 31, 2020
Enrollment
252 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant